<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/ijms27031309</dc:identifier><dc:language>eng</dc:language><dc:creator>Serrano-Casorrán, Carolina</dc:creator><dc:creator>Rodríguez-Zapater, Sergio</dc:creator><dc:creator>Rodríguez-Panadero, Francisco</dc:creator><dc:creator>Gómez, Raquel</dc:creator><dc:creator>Bonastre, Cristina</dc:creator><dc:creator>Guirola, José Andrés</dc:creator><dc:creator>Rodríguez, José</dc:creator><dc:creator>Gregorio, Miguel Ángel de</dc:creator><dc:title>The local damage and systemic inflammation induced by a biodegradable polydioxanone Stent implanted in the rabbit trachea decreases markedly with Stent degradation</dc:title><dc:identifier>ART-2026-148715</dc:identifier><dc:description>Biodegradable tracheal stents have been developed to overcome the limitations of metallic and removable stents in benign airway disease. This study evaluated the local and systemic inflammatory response induced by a biodegradable polydioxanone tracheal stent in a rabbit model. Twenty-one rabbits were assigned to three follow-up groups (30, 60, and 90 days). In each group, six animals received a tracheal stent, and one served as a sham control. Clinical status and respiratory symptoms were monitored, and serial peripheral blood interleukin-8 (IL-8) levels were measured. At the end of follow-up, tracheoscopy, IL-8 quantification in tracheal lavage, and necropsy were performed. No deaths or severe respiratory symptoms occurred. Tracheoscopic findings were significantly less severe after stent degradation, with reduced congestion (p = 0.030), inflammation (p = 0.003), and secretions (p = 0.030). Two granulomas and two cases of stenosis were identified. Mean IL-8 expression in tracheal lavage (relative quantification, RQ) was 14,129 ± 3007 when the stent was present and 426 ± 100 after degradation (p = 0.003). Blood IL-8 expression increased significantly on day 1 compared with baseline (p = 0.022) and subsequently decreased (p = 0.034). Inflammatory and structural alterations induced by a polydioxanone tracheal stent decrease after stent degradation.</dc:description><dc:date>2026</dc:date><dc:source>http://zaguan.unizar.es/record/170177</dc:source><dc:doi>10.3390/ijms27031309</dc:doi><dc:identifier>http://zaguan.unizar.es/record/170177</dc:identifier><dc:identifier>oai:zaguan.unizar.es:170177</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/DGA/B36-23R</dc:relation><dc:identifier.citation>International Journal of Molecular Sciences 27, 3 (2026), 1309 [12 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>